A Behcet-kór multiszisztémás autoimmun betegség változatos klinikai megjelenési tünetekkel. Hazánkban a Behcet-kór a ritka betegségek közé tartozik, a témával foglalkozó közlemények száma elenyésző. Történelmünk során a népcsoportok keveredése, valamint a világszerte növekvő prevalencia és a szerzők tapasztalata is arra utal, hogy a betegség előfordulására az eddig vártnál nagyobb gyakorisággal kell számítani. A szerzők felhívják a figyelmet erre a sokoldalúan megjelenő, sok szakterületet érintő betegségre. A diagnózis nagy kihívást jelent a klinikus számára, akinek tisztában kell lennie a lehetséges tünetek spektrumával és kombinációival. Irodalmi adatok és saját tapasztalataik alapján a szerzők összefoglalják a betegség eddig ismert patogenetikai és patomechanikai tényezőit és a diagnózishoz nélkülözhetetlen szimptómák rendszerét, a kezelés lehetőségeit. A közleménnyel a szerzők a diagnosztikát, a magyar betegpopuláció feltérképezését és jobb kezelését szeretnék segíteni, és kezdeményezik hazai Behcet-regiszter felállítását. Orv. Hetil., 2013, 154, 93–101.
Behcet, H.: Über rezidivierende Aphthose, durch ein virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol. Wochenschr., 1937, 105, 1152–1157.
Behcet H. , 'Über rezidivierende Aphthose, durch ein virus verursachte Geschwure am Mund, am Auge und an den Genitalien ' (1937 ) 105 Dermatol. Wochenschr. : 1152 -1157 .
Zouboulis, C. C.: Epidemiology of Adamantiades-Behcet Disease. Ann. Med. Interne (Paris), 1999, 150, 488–498.
Zouboulis C. C. , 'Epidemiology of Adamantiades-Behcet Disease ' (1999 ) 150 Ann. Med. Interne (Paris) : 488 -498 .
Cho, S. B., Cho, S., Bang, D.: New insights in the clinical understanding of Behcet’s disease. Yonsei Med. J., 2012, 53, 35–42.
Bang D. , 'New insights in the clinical understanding of Behcet’s disease ' (2012 ) 53 Yonsei Med. J. : 35 -42 .
Yurkadul, S., Yazici, Y.: Epidemiology of Behcet’s syndrome and regional differences in disease expression. In: Yazici, A., Yazici, H. (eds.). Behcet’s syndrome. 1th ed., Springer, New York, 2010, 35–52.
Yazici Y. , '', in Behcet’s syndrome , (2010 ) -.
Koné-Paut, I., Yurdakul, S., Bahabri, S. A., et al.: Clinical features of Behcet’s disease in children: an international collaborative study of 86 cases. J. Pediatr., 1998, 132, 721–725.
Bahabri S. A. , 'Clinical features of Behcet’s disease in children: an international collaborative study of 86 cases ' (1998 ) 132 J. Pediatr. : 721 -725 .
Sungur, G., Hazirolan, D., Hekimoglu, E., et al.: Late-onset Behcet’s disease: Demografic, clinical, and ocular features. Graefes Arch. Clin. Exp. Ophthalmol., 2010, 248, 1325–1330.
Hekimoglu E. , 'Late-onset Behcet’s disease: Demografic, clinical, and ocular features ' (2010 ) 248 Graefes Arch. Clin. Exp. Ophthalmol. : 1325 -1330 .
Bang, D. S., Oh, S. H., Lee, K. H., et al.: Influence of sex on patients with Behcet’s disease in Korea. J. Korean Med. Sci., 2003, 18, 231–235.
Lee K. H. , 'Influence of sex on patients with Behcet’s disease in Korea ' (2003 ) 18 J. Korean Med. Sci. : 231 -235 .
Wallace, G. R., Niemczyk, E.: Genetics in ocular inflammation – basic principles. Ocul. Immunol. Inflamm., 2011, 19, 10–18.
Niemczyk E. , 'Genetics in ocular inflammation – basic principles ' (2011 ) 19 Ocul. Immunol. Inflamm. : 10 -18 .
Verity, J. H., Marr, J. E., Ohno, S., et al.: Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens, 1999, 54, 213–220.
Ohno S. , 'Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives ' (1999 ) 54 Tissue Antigens : 213 -220 .
Meguro, A., Inoko, H., Ota, M., et al.: Genetics of Behcet disease inside and outside the MHC. Ann. Rheum. Dis., 2010, 69, 747–754.
Ota M. , 'Genetics of Behcet disease inside and outside the MHC ' (2010 ) 69 Ann. Rheum. Dis. : 747 -754 .
Mizuki, M., Ota, N., Kimura, S., et al.: Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet’s disease. Proc. Natl. Acad. Sci. USA, 1997, 94, 1298–1303.
Kimura S. , 'Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet’s disease ' (1997 ) 94 Proc. Natl. Acad. Sci. USA : 1298 -1303 .
Mizuki, N., Meguro, A., Ota, M., et al.: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat. Genet., 2010, 42, 703–706.
Ota M. , 'Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci ' (2010 ) 42 Nat. Genet. : 703 -706 .
Direskeneli, H.: Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis., 2001, 60, 996–1002.
Direskeneli H. , 'Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51 ' (2001 ) 60 Ann. Rheum. Dis. : 996 -1002 .
Kaneko, F., Oyama, N., Yanagihori, H., et al.: The role of streptococcal hypersensitivity in the pathogenesis of Behcet’s disease. Eur. J. Dermatol., 2008, 18, 489–498.
Yanagihori H. , 'The role of streptococcal hypersensitivity in the pathogenesis of Behcet’s disease ' (2008 ) 18 Eur. J. Dermatol. : 489 -498 .
Lee, J., Wu, W., Lee, H., et al.: The cross-reactivity of anti human α-enolase antibody in the sera of Behcet’s disease patients to Streptococcus sanguis antigen. Korean J. Invest. Dermatol., 2005, 12, 83–92.
Lee H. , 'The cross-reactivity of anti human α-enolase antibody in the sera of Behcet’s disease patients to Streptococcus sanguis antigen ' (2005 ) 12 Korean J. Invest. Dermatol. : 83 -92 .
Moon, C. M., Cheon, J. H., Shin, J. K., et al.: Prediction of free bowel perforation in patients with intestinal Behcet’s disease using clinical and colonoscopic findings. Dig. Dis. Sci., 2010, 55, 2904–2911.
Shin J. K. , 'Prediction of free bowel perforation in patients with intestinal Behcet’s disease using clinical and colonoscopic findings ' (2010 ) 55 Dig. Dis. Sci. : 2904 -2911 .
Galeone, M., Colucci, R., D’Erme, A. M., et al.: Potential infectious etiology of Behçet’s disease. Patholog. Res. Int., 2012, 2012, ID 595380 DOI:10.1155/2012/595380
D’Erme A. M. , 'Potential infectious etiology of Behçet’s disease ' (2012 ) Patholog. Res. Int. : -.
Mendoza-Pinto, C., Garcia-Carrasco, M., Jiménez-Hernández, M., et al.: Etiopathogenesis of Behcet’s disease. Autoimmunity Rev., 2010, 9, 241–245.
Jiménez-Hernández M. , 'Etiopathogenesis of Behcet’s disease ' (2010 ) 9 Autoimmunity Rev. : 241 -245 .
Hatemi, G., Yazici, H.: Behcet’s syndrome and micro-organisms. Best Pract. Res. Clin. Rheumatol., 2011, 25, 389–406.
Yazici H. , 'Behcet’s syndrome and micro-organisms ' (2011 ) 25 Best Pract. Res. Clin. Rheumatol. : 389 -406 .
Lee, K. H., Chung, H. S., Kim, H. S., et al.: Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet’s disease. Arthritis Rheum., 2003, 48, 2025–2035.
Kim H. S. , 'Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet’s disease ' (2003 ) 48 Arthritis Rheum. : 2025 -2035 .
Krause, I., Weinberger, A.: Behcet’s disease. Curr. Opin. Rheumatol., 2008, 20, 82–87.
Weinberger A. , 'Behcet’s disease ' (2008 ) 20 Curr. Opin. Rheumatol. : 82 -87 .
Pay, S., Simsek, I., Erdem, H., et al.: Immunopathogenesis of Behcet’s disease with special emphasize on the possible role on antigen presenting cells. Rheumatol. Int., 2007, 27, 417–424.
Erdem H. , 'Immunopathogenesis of Behcet’s disease with special emphasize on the possible role on antigen presenting cells ' (2007 ) 27 Rheumatol. Int. : 417 -424 .
Ahn, J. K., Yu, H. G., Chung, H., et al.: Intraocular cytokine environment in active Behcet uveitis. Am. J. Ophthalmol., 2006, 142, 429–434.
Chung H. , 'Intraocular cytokine environment in active Behcet uveitis ' (2006 ) 142 Am. J. Ophthalmol. : 429 -434 .
Geri, G., Terrier, B., Rosenzwajg, M., et al.: Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J. Allergy Clin. Immunol., 2011, 128, 655–664.
Rosenzwajg M. , 'Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease ' (2011 ) 128 J. Allergy Clin. Immunol. : 655 -664 .
Jiang, S., Liu, X., Luo, L., et al.: Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Mol. Vis., 2011, 17, 1425–1430.
Luo L. , 'Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery ' (2011 ) 17 Mol. Vis. : 1425 -1430 .
Shim, J., Lee, E. S., Park, S., et al.: CD4(+) CD25(+) regulatory T cells ameliorate Behcet’s disease-like symptoms in a mouse model. Cytotherapy, 2011, 13, 835–847.
Park S. , 'CD4(+) CD25(+) regulatory T cells ameliorate Behcet’s disease-like symptoms in a mouse model ' (2011 ) 13 Cytotherapy : 835 -847 .
Kapsimali, V. D., Kanakis, M. A., Vaiopoulos, G. A., et al.: Etiopathogenesis of Behcet’s disease with emphasis on the role of immunological abberations. Clin. Rheumatol., 2010, 29, 1211–1216.
Vaiopoulos G. A. , 'Etiopathogenesis of Behcet’s disease with emphasis on the role of immunological abberations ' (2010 ) 29 Clin. Rheumatol. : 1211 -1216 .
Suzuki Kurokawa, M., Suzuki, N.: Behçet’s disease. Clin. Exp. Med., 2004, 4, 10–20.
Suzuki N. , 'Behçet’s disease ' (2004 ) 4 Clin. Exp. Med. : 10 -20 .
International Study Group for Behcet’s Disease: Criteria for diagnosis of Behcet’s disease. Lancet, 1990, 335, 1078–1080.
'Criteria for diagnosis of Behcet’s disease ' (1990 ) 335 Lancet : 1078 -1080 .
Mat, M. C., Göksugur, N., Engin, B., et al.: The frequency of scarring after genital ulcers in Behcet’s syndrome: a prospective study. Int. J. Dermatol., 2006, 45, 554–556.
Engin B. , 'The frequency of scarring after genital ulcers in Behcet’s syndrome: a prospective study ' (2006 ) 45 Int. J. Dermatol. : 554 -556 .
Akova, Y. A., Göngör, S. G.: Ocular involvement in Behcet Disease. In: Khatami, M. (ed.). Inflammation, chronic disease and cancer-cell and molecular biology, immunology and clinical bases. InTech, 2012, 391–415. http://intechopen.com/books/inflammation-chronic-disease-and-cancer-cell-and-molecular-biology-immunology-and-clinical-bases
Tugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., et al.: Uveitis in Behcet disease: an analysis of 880 patients. Am. J. Ophthalmol., 2004, 138, 373–380.
Altan-Yaycioglu R. , 'Uveitis in Behcet disease: an analysis of 880 patients ' (2004 ) 138 Am. J. Ophthalmol. : 373 -380 .
Dinc, A., Karaayvaz, M., Caliskaner, A. Z., et al.: Dermographism and atopy in patients with Behcet’s disease. J. Investig. Allergol. Clin. Immunol., 2000, 10, 368–371.
Caliskaner A. Z. , 'Dermographism and atopy in patients with Behcet’s disease ' (2000 ) 10 J. Investig. Allergol. Clin. Immunol. : 368 -371 .
Vaiopoulos, G., Konstantopoulou, P., Evangelatos, N., et al.: The spectrum of mucocutaneous manifestation in Adamantiades-Behcet’s disease in Greece. J. Eur. Acad. Dermatol. Venereol., 2010, 24, 434–438.
Evangelatos N. , 'The spectrum of mucocutaneous manifestation in Adamantiades-Behcet’s disease in Greece ' (2010 ) 24 J. Eur. Acad. Dermatol. Venereol. : 434 -438 .
Cheon, J. H., Han, D. S., Park, J. Y., et al., Korean IBD Study Group: Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet’s disease. Inflamm. Bowel Dis., 2011, 17, 605–613.
Park J. Y. , 'Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet’s disease ' (2011 ) 17 Inflamm. Bowel Dis. : 605 -613 .
Lee, S. K., Kim, B. K., Kim, T. I., et al.: Differential diagnosis of intestinal Behcet’s disease and Crohn’s disease by colonoscopic findings. Endoscopy, 2009, 41, 9–16.
Kim T. I. , 'Differential diagnosis of intestinal Behcet’s disease and Crohn’s disease by colonoscopic findings ' (2009 ) 41 Endoscopy : 9 -16 .
Cheon, J. H., Kim, E. S., Shin, S. J., et al.: Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am. J. Gastroenterol., 2009, 104, 2492–2499.
Shin S. J. , 'Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers ' (2009 ) 104 Am. J. Gastroenterol. : 2492 -2499 .
Filik, L., Biyikoglu, I.: Differentiation of Behcet’s disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiase antibody and anti-neutrophilic cytoplasmic antibody. World J. Gastroenterol., 2008, 14, 7271.
Biyikoglu I. , 'Differentiation of Behcet’s disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiase antibody and anti-neutrophilic cytoplasmic antibody ' (2008 ) 14 World J. Gastroenterol. : 7271 -.
Hatemi, G., Fresko, I., Tascilar, K., et al.: Increased enthesopathy among Behcet’s syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum., 2008, 58, 1539–1545.
Tascilar K. , 'Increased enthesopathy among Behcet’s syndrome patients with acne and arthritis: an ultrasonography study ' (2008 ) 58 Arthritis Rheum. : 1539 -1545 .
Yazici, H., Tuzlaci, M., Yurkadul, S.: A controlled survey of sacroiliitis in Behcet’s disease. Ann. Rheum. Dis., 1981, 40, 558–559.
Yurkadul S. , 'A controlled survey of sacroiliitis in Behcet’s disease ' (1981 ) 40 Ann. Rheum. Dis. : 558 -559 .
Melikoglu, M., Urgulu, S., Tascilar, K., et al.: Large vessel involvement in Behcet’s syndrome. A retrospective survey. Ann. Rheum. Dis., 2008, 67 (SII), 67.
Tascilar K. , 'Large vessel involvement in Behcet’s syndrome. A retrospective survey ' (2008 ) 67 Ann. Rheum. Dis. : 67 -.
Hamuryudan, V., Er, T., Seyahi, E., et al.: Pulmonary artery aneurysms in Behcet syndrome. Am. J. Med., 2004, 117, 867–870.
Seyahi E. , 'Pulmonary artery aneurysms in Behcet syndrome ' (2004 ) 117 Am. J. Med. : 867 -870 .
Kahraman, O., Celebi-Onder, S., Kamali, S., et al.: Long-term course of deep venous thrombosis in patients with Behcet’s disease. Arthritis Rheum., 2003, 48 (Suppl 9), S385.
Kamali S. , 'Long-term course of deep venous thrombosis in patients with Behcet’s disease ' (2003 ) 48 Arthritis Rheum. : S385 -.
Ahn, J. K., Lee, Y. S., Jeon, C. H., et al.: Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin. Rheumatol., 2008, 27, 201–205.
Jeon C. H. , 'Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation ' (2008 ) 27 Clin. Rheumatol. : 201 -205 .
Geri, G., Weschler, B., Thi Huong, du L., et al.: Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore), 2012, 91, 25–34.
Thi Huong du L. , 'Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature ' (2012 ) 91 Medicine (Baltimore) : 25 -34 .
Alkan, A., Goktan, A., Karincaoglu, Y., et al.: Brain perfusion MRI findings in patients with Behcet’s disease. Sci. World J., 2012, DOI:10.1100/2012/261502
Karincaoglu Y. , 'Brain perfusion MRI findings in patients with Behcet’s disease ' (2012 ) Sci. World J. : -.
Al-Araji, A., Kidd, D. P.: Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol., 2009, 8, 192–204.
Kidd D. P. , 'Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management ' (2009 ) 8 Lancet Neurol. : 192 -204 .
Köse, O.: Development of immunopathogenesis Strategies to Treat Behcet’s disease. Patholog. Res. Int., 2012, 2012, 261989. DOI: 10.1155/2012/261989
Köse O. , 'Development of immunopathogenesis Strategies to Treat Behcet’s disease ' (2012 ) 2012 Patholog. Res. Int. : 261989 -.
Heo, J., Sepah, Y. J., Yohannan, J., et al.: The role of biologic agents in the management of non-infectious uveitis. Expert Opin. Biol. Ther., 2012, 12, 995–1008.
Yohannan J. , 'The role of biologic agents in the management of non-infectious uveitis ' (2012 ) 12 Expert Opin. Biol. Ther. : 995 -1008 .
Lawton, G., Bhakta, B. B., Chamberlain, M. A., et al.: The Behcet’s disease activity index. Rheumatology (Oxford), 2004, 43, 73–78.
Chamberlain M. A. , 'The Behcet’s disease activity index ' (2004 ) 43 Rheumatology (Oxford) : 73 -78 .